Work

Thu0328 Safety and Efficacy of Subcutaneous Tocilizumab in Systemic Sclerosis: Results From the Open-label Period of the Phase 3 Focussced Trial

Year: 2020

Type: conference-abstract

Source: Annals of the Rheumatic Diseases

DOI: 10.1136/annrheumdis-2020-eular.1535

Authors: D. Khanna, C.J.F. Lin, H. Spotswood, J. Siegel, D. Furst, C. Denton

Institutions: University of Michigan, Genentech, Roche (United Kingdom), University of California, Los Angeles, University College London

Language: English

Topic: Systemic Sclerosis and Related Diseases

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3045032056

Cites:

Cited by: 3

Related to: 10